![Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A - Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A -](https://www.indianjurol.com/articles/2014/30/1/images/IndianJUrol_2014_30_1_28_124202_t3.jpg)
Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A -
![Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening | Scientific Reports Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-77668-w/MediaObjects/41598_2020_77668_Fig1_HTML.png)
Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening | Scientific Reports
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial | PLOS ONE
![Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3 Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3](https://www.frontiersin.org/files/Articles/908956/fonc-12-908956-HTML/image_m/fonc-12-908956-g001.jpg)
Frontiers | New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283812008342-gr2.jpg)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam - ScienceDirect
![The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11255-019-02261-8/MediaObjects/11255_2019_2261_Fig1_HTML.png)
The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer | SpringerLink
![Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.pcan.4500957/MediaObjects/41391_2007_Article_BF4500957_Fig1_HTML.jpg)
Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels | Prostate Cancer and Prostatic Diseases
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/4966e23dbbb57e0e806f4c569f2439f76166ebb8.gif)
SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection
Sunnybrook Health Sciences Centre ~ News & Media ~ Prostate Cancer Risk Online Tool Supports More Dialogue
![A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-58836-4/MediaObjects/41598_2020_58836_Fig1_HTML.png)
A predictive model for prostate cancer incorporating PSA molecular forms and age | Scientific Reports
![Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower - Walz - 2008 - Cancer - Wiley Online Library Percent free prostate‐specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower - Walz - 2008 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/f9066e49-807c-4d02-923f-82b6138470d6/cncr.v129.9.cover.jpg?trick=1681023031143)